Trial Profile
Outcome Trial Evaluating the Efficacy and Safety of Norditropin® in Adult Patients on Chronic Haemodialysis A Randomised, Double-blind, Parallel group, placebo controlled, Multi-centre trial
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 23 Dec 2021
Price :
$35
*
At a glance
- Drugs Somatropin (Primary)
- Indications Nutrition disorders
- Focus Registrational; Therapeutic Use
- Acronyms OPPORTUNITY
- Sponsors Novo Nordisk
- 20 Dec 2021 This trial has been completed in Hungary, according to European Clinical Trials Database record.
- 05 Oct 2021 Trial has been completed in France (global end of the trial 2008-12-19 ) as per European Clinical Trials Database.
- 12 Apr 2014 New trial record